(Q34298213)

1 August 2017

1 reference

23 October 2022

How Ebola virus counters the interferon system (English)

1 reference

1 August 2017

Orthoebolavirus zairense

0 references

S Pöhlmann

2

0 references

author name string

A Kühl

series ordinal

1

1 reference

1 August 2017

1 September 2012

2 references

Zoonoses and Public Health

1 August 2017

23 October 2022

2 references

1 August 2017

23 October 2022

59 Suppl 2

1 reference

1 August 2017

116-131

1 reference

Discovery of swine as a host for the Reston ebolavirus

1 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The Ebola virus VP35 protein functions as a type I IFN antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Induction of type I interferon by RNA viruses: cellular receptors and their substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Differential recognition of viral RNA by RIG-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The role of the Type I interferon response in the resistance of mice to filovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ectodomain shedding of the glycoprotein GP of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Filoviruses: Interactions with the host cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Molecular determinants of Ebola virus virulence in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The dsRNA protein kinase PKR: virus and cell control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Type 1 interferons and the virus-host relationship: a lesson in détente .

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The ecology of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The Ebola virus VP35 protein is a suppressor of RNA silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Interferon-induced Mx proteins in antiviral host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Filovirus assembly and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola and marburg hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

IRF-7 is the master regulator of type-I interferon-dependent immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

How Ebola virus infects cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Fold prediction of VP24 protein of Ebola and Marburg viruses using de novo fragment assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Fruit bats as reservoirs of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Structure of the Ebola VP35 interferon inhibitory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

New developments in the induction and antiviral effectors of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The IFITM proteins inhibit HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

A new Ebola virus nonstructural glycoprotein expressed through RNA editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Plasma membrane rafts play a critical role in HIV-1 assembly and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Tetherin inhibits HIV-1 release by directly tethering virions to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Interferon-inducible antiviral effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Inhibition of Lassa and Marburg virus production by tetherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

JAK-STAT signaling: from interferons to cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

A diverse range of gene products are effectors of the type I interferon antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The small interferon-induced transmembrane genes and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Experimental inoculation of plants and animals with Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

A system for functional analysis of Ebola virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Budding capability of the influenza virus neuraminidase can be modulated by tetherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1863-2378.2012.01454.X

Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22958256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22958256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22958256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1863-2378.2012.01454.X

1 reference

1 August 2017

0 references

1 reference

PubMed ID

22958256